Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 15,972 | 19,482 | 14,359 | 18,237 | 17,529 |
| Cost of Goods | 9,728 | 11,909 | 9,542 | 12,148 | 11,676 |
| Gross Profit | 6,244 | 7,573 | 4,817 | 6,088 | 5,853 |
| Operating Expenses | 4,827 | 5,431 | 4,067 | 4,183 | 4,383 |
| Operating Income | 2,145 | 3,051 | 1,292 | 2,054 | 2,146 |
| Interest Expense | 108 | 117 | 82 | 83 | 50 |
| Other Income | 68 | 50 | 51 | 267 | 30 |
| Pre-tax Income | 2,104 | 2,984 | 1,262 | 2,238 | 2,126 |
| Income Tax | 583 | 824 | 368 | 557 | 619 |
| Net Income Continuous | 1,521 | 2,160 | 893 | 1,682 | 1,507 |
| Minority Interests | -21 | -43 | 0 | -56 | -18 |
| Net Income | $1,542 | $2,203 | $893 | $1,738 | $1,525 |
| EPS Basic Total Ops | 0.05 | 0.08 | 0.03 | 0.06 | 0.05 |
| EPS Basic Continuous Ops | 0.05 | 0.07 | 0.03 | 0.06 | 0.05 |
| EPS Diluted Total Ops | 0.05 | 0.08 | 0.03 | 0.06 | 0.05 |
| EPS Diluted Continuous Ops | 0.05 | 0.07 | 0.03 | 0.06 | 0.05 |
| EBITDA(a) | $2,729 | $3,415 | $1,625 | $2,285 | $2,433 |